« Return to News | Clinical Intelligence

The CenterWatch Monthly, February 2012

Friday, February 3, 2012 12:01 PM

Anticipating the rise of virtual drug development

With the rising cost of drug development and a continued shortage of new products entering the marketplace, the virtual pharma model is expected to become more prevalent going forward, particularly as pharma companies have shown greater interest in buying assets from virtual companies. Benefits of the virtual model include less overhead and faster…

 

Closing investigative site operations a complex process

In light of the shrinking investigative site landscape reported and detailed in our January issue, CenterWatch has conducted in-depth case studies of sites closing their operations. Site personnel offer insights into insights into the challenges of exiting the business and how to better manage the process. The site profiles, which each took a different path to closing shop, detail the numerous logistics involved, from ensuring patient safety and considering their employees’ futures to…

 

Eye On Shire

Shire is a rapidly growing, global specialty biopharmaceutical company aiming “to enable people with life-altering conditions to lead better lives.” While based in the U.K. and U.S., it also directly markets its products in over 50 countries. Shire’s stated goal is to have half of its sales originate from beyond the U.S. and European…

 

 To read the full articles for this issue of The CenterWatch Monthly, please click here for subscription information.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

December 17

Medici Global says its Alzheimer's Facebook page demonstrates the need for more early detection trials

Analysts: Expect more equity purchases of CROs in 2013

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

January 2013

Parexel celebrates 30 years of change, growth
CRO's founder and chairman reflects on challenges of the past, present and future

Strategies for increasing patient diversity in trials
Sponsors look to improve racial, ethnic recruitment without going overseas

Already a subscriber?
Log in to your digital subscription.

Purchase the January issue.

Subscribe to The CenterWatch Monthly.

December 2012

Publicity, regulation tightening reins on use of KOLs
Debate rages over need to revamp how sponsors use, pay medical experts

Time may be right to makeover the investigator brochure
Size, complexity prevent critical document from being thoroughly read

Already a subscriber?
Log in to your digital subscription.

Purchase the December issue.

Subscribe to The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.